{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:07:26Z","timestamp":1759936046408},"publisher-location":"New York, NY","reference-count":14,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493968671"},{"type":"electronic","value":"9781493968695"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-6869-5_2","type":"book-chapter","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T09:58:42Z","timestamp":1491213522000},"page":"15-28","source":"Crossref","is-referenced-by-count":3,"title":["Development of Recombinant Canarypox Viruses Expressing Immunogens"],"prefix":"10.1007","author":[{"given":"D\u00e9bora","family":"Garanzini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Paula","family":"Del M\u00e9dico-Zajac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Calamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"issue":"30","key":"2_CR1","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1016\/j.vaccine.2006.11.066","volume":"25","author":"H Poulet","year":"2007","unstructured":"Poulet H, Minke J, Pardo MC et al (2007) Development and registration of recombinant veterinary vaccine. The example of the canarypox vector platform. Vaccine 25(30):5606\u20135612","journal-title":"Vaccine"},{"issue":"1","key":"2_CR2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nrmicro2240","volume":"8","author":"SJ Draper","year":"2010","unstructured":"Draper SJ, Heeney JL (2010) Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8(1):62\u201373","journal-title":"Nat Rev Microbiol"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1743-422X-8-49","volume":"8","author":"SC Weli","year":"2011","unstructured":"Weli SC, Tryland M (2011) Avipoxviruses: infection biology and their use as vaccine vectors. Virol J 8:49","journal-title":"Virol J"},{"key":"2_CR4","volume-title":"Vaccinia virus and poxvirology methods and protocols","author":"C Staib","year":"2004","unstructured":"Staib C, Drexler I, Sutter G (2004) Construction and Isolation of Recombinant MVA. In: Isaacs SN (ed) Vaccinia virus and poxvirology methods and protocols, 1st edn. Humana, Totowa, NJ","edition":"1st"},{"key":"2_CR5","unstructured":"Calamante G, Conte Grand MD, Carrillo EC (2010) Argentinian Patent AR052743B1"},{"key":"2_CR6","unstructured":"Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual, 4th edition. In: Inglis J, Boyle A, Gann A (eds) Expressing cloned genes for protein production, purification and analysis, chapter 19, vol 3. Cold Spring Harbor Laboratory Press, New York, pp 1602\u20131630"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01702566","volume":"6","author":"DB Boyle","year":"1992","unstructured":"Boyle DB (1992) Quantitative assessment of poxvirus promoters in fowlpox and vaccinia virus recombinants. Virus Genes 6:281\u2013290","journal-title":"Virus Genes"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0264-410X(94)00028-L","volume":"13","author":"J Taylor","year":"1995","unstructured":"Taylor J, Meignier B, Tartaglia J et al (1995) Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine 13:539\u2013549","journal-title":"Vaccine"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/viro.1999.9648","volume":"256","author":"H Amano","year":"1999","unstructured":"Amano H, Morikawa S, Shimizu H et al (1999) Identification of the canarypoxvirus thymidine kinase gene and insertion of foreign genes. Virology 256:280\u2013290","journal-title":"Virology"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1590\/S1517-83822014000100032","volume":"45","author":"FA Zanetti","year":"2014","unstructured":"Zanetti FA, Conte Grand MD, Mitarotonda RC et al (2014) Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens. Braz J Microbiol 45:231\u2013234","journal-title":"Braz J Microbiol"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","volume":"158","author":"R Blasco","year":"1995","unstructured":"Blasco R, Moss B (1995) Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157\u2013162","journal-title":"Gene"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/eji.1830161203","volume":"16","author":"BE Coupar","year":"1986","unstructured":"Coupar BE, Andrew ME, Both GW, Boyle DB (1986) Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur J Immunol 16:1479\u20131487","journal-title":"Eur J Immunol"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/JVI.60.2.436-449.1986","volume":"60","author":"J Rosel","year":"1986","unstructured":"Rosel J, Earl P, Weir J, Moss B (1986) Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment. J Virol 60:436\u2013449","journal-title":"J Virol"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/JVI.78.1.353-366.2004","volume":"78","author":"ER Tulman","year":"2004","unstructured":"Tulman ER, Afonso CL, Lu Z et al (2004) The genome of canarypox virus. J Virol 78:353\u2013366","journal-title":"J Virol"}],"container-title":["Methods in Molecular Biology","Recombinant Virus Vaccines"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-6869-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T17:49:06Z","timestamp":1601833746000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-6869-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493968671","9781493968695"],"references-count":14,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-6869-5_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017]]}}}